Abstract: A wireless power transfer apparatus includes a first control system, a first energy transmission system, and a second energy transmission system. The first control system is coupled to the first energy transmission system, and inputs an energy transmission signal to the first energy transmission system. The first energy transmission system is coupled to the second energy transmission system, and inputs some of the energy transmission signals obtained from the first control system into the second energy transmission system. Both the energy transmission signal obtained by the first energy transmission signal from the first control system and an energy transmission signal obtained by the second energy transmission system from the first energy transmission system supply power to a target device.

Abstract: Methods and systems of building a knowledge graph based on event-based ontology of a scene and vehicle trajectory in the scene. Image data corresponding to a plurality of scenes captured by one or more cameras is received. Event-based ontology data corresponding to events occurring in the plurality of scenes is received. Via an object-tracking machine-learning model, the system determines (i) a presence of a plurality of vehicles in the image data, and (ii) a plurality of vehicle trajectories, each vehicle trajectory associated with a respective one of the vehicles. Using a clustering model, the vehicle trajectories are clustered. A knowledge graph is augmented based on the clustered vehicle trajectories and the event-based ontology.

Abstract: A wearable device is configured to be worn on a head of a user. The wearable device includes a sensing module and an image forming module. The sensing module is configured to sense an intersection of sight lines of two eyes of the user. The image forming module is coupled with the sensing module. The image forming module is configured to project a pattern onto one of the two eyes of the user, such that the pattern is visually located at a first position at which the intersection of sight lines locates.

Abstract: A stabilized aFGF composition or a method for stabilization of the pharmaceutical composition comprising aFGF are provided. The composition comprises aFGF, a citric acid compound and other excipients. The method for improving stability of aFGF in the form of a liquid formulation or a lyophilized formulation so as to increase storage stability is also provided.

Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Abstract: The present disclosure provides an eye-safe laser triangulation measurement system, including a laser transmitter, an optical projection apparatus, a laser beam capturing unit, a cooperation unit, and an image processing apparatus. The laser transmitter is configured to generate point pulse laser of a pulse laser beam. The optical projection apparatus is disposed at a front end of the laser transmitter, and is configured to convert the point pulse laser into a line laser. The laser beam capturing unit is configured to capture reflected light obtained by the line laser at a target position to obtain a laser image. The cooperation unit is configured to control on and off of the laser transmitter, and control capture of the laser beam capturing unit. The image processing apparatus is configured to perform 3D modeling on the laser image to obtain a distance to the target position.

Abstract: A method of checking file data is provided. The method includes obtaining text information of a test file. The text information of the test file is converted into vectors, thus vectors corresponding to the test file are obtained. A quality category of the test file is obtained based on the vectors corresponding to the test file. Once the test file is determined not to meet a requirement according to the quality category of the test file, a template file corresponding to the test file is provided.

Abstract: A test device stores and runs a test container, and the test container includes a plurality of cyberattack tools. The test device receives a user command from a user. During the runtime of the test container, the test device analyzes the user command to launch a test of cyberattack, such that the cyber defense mechanism of the device under test is tested.

Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.

Abstract: An image processing method includes the following operations: generate a display image by a display device; obtain an eye focus position by a photographic device; sense a head rotation angle to generate a head movement information by a sensing device; sense a body movement to generate a body movement information by a monitoring device; generate a focus target in the display image according to the eye focus position, generate a reference axis according to the focus target, and generate the display image according to the reference axis, the head movement information and the body movement information by a processing device.

Abstract: Disclosed are synthetic diamond materials for quantum and optical applications, such as quantum information processing, quantum key distribution, quantum repeaters, and quantum sensing devices, based on spin defects in diamond. This includes methods for synthesizing and treating diamond in order to create spin defects with improved spin coherence and optical emission properties, as well as treating the diamond to eliminate unwanted defects that degrade these properties.

Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.

Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.

Abstract: An image processing method includes the following operations: generate a display image by a display device; obtain an eye focus position by a photographic device; sense a head rotation angle to generate a head movement information by a sensing device; sense a body movement to generate a body movement information by a monitoring device; generate a focus target in the display image according to the eye focus position, generate a reference axis according to the focus target, and generate the display image according to the reference axis, the head movement information and the body movement information by a processing device.

Abstract: The present invention relates to kits and prefilled syringes comprising pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as methods of treating pain using such formulations.

Abstract: The present disclosure provides an eye-safe laser triangulation measurement system, including a laser transmitter, an optical projection apparatus, a laser beam capturing unit, a cooperation unit, and an image processing apparatus. The laser transmitter is configured to generate point pulse laser of a pulse laser beam. The optical projection apparatus is disposed at a front end of the laser transmitter, and is configured to convert the point pulse laser into a line laser. The laser beam capturing unit is configured to capture reflected light obtained by the line laser at a target position to obtain a laser image. The cooperation unit is configured to control on and off of the laser transmitter, and control capture of the laser beam capturing unit. The image processing apparatus is configured to perform 3D modeling on the laser image to obtain a distance to the target position.

Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.